Reports for SANOFI GENZYME, A DIVISION OF SANOFI-AVENTIS CANADA INC

Company Name

SANOFI GENZYME, A DIVISION OF SANOFI-AVENTIS CANADA INC

Totals

Shortage reports

12

Actual shortage: 1 (8%)
Anticipated shortage: 0 (0%)
Avoided shortage: 2 (17%)
Resolved: 9 (75%)

Discontinuation Reports

0

To be discontinued: 0
Discontinued: 0
Reversed: 0

Late reports

1 (8%)

Overdue reports

0 (0%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
AUBAGIO 14MG TABLET Resolved 2022-04-25 2022-05-04 159348
CAPRELSA 100MG TABLET Avoided shortage 2022-02-15 2022-06-30 155030
CAPRELSA 100MG TABLET Resolved 2023-01-30 2023-02-08 182714
CAPRELSA 300MG TABLET Avoided shortage 2022-02-15 2022-04-08 155058
MABCAMPATH 30MG SOLUTION Resolved 2020-02-21 2020-06-18 106962
MABCAMPATH 30MG SOLUTION Resolved 2023-10-18 2023-12-19 207255
MYOZYME 50MG POWDER FOR SOLUTION Resolved 2022-11-30 2022-12-07 176406
THYROGEN 0.9MG POWDER FOR SOLUTION Resolved 2022-01-13 2022-02-08 152688
THYROGEN 0.9MG POWDER FOR SOLUTION Resolved 2022-05-16 2022-06-09 160682
THYROGEN 0.9MG POWDER FOR SOLUTION Resolved 2022-10-28 2023-01-28 172865
THYROGEN 0.9MG POWDER FOR SOLUTION Resolved 2023-03-15 2023-04-24 187119
THYROGEN 0.9MG POWDER FOR SOLUTION Actual shortage 2023-05-05 2023-12-18 191764

Showing 1 to 12 of 12

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports

Showing 1 to 0 of 0